Far too often, late-stage cancer patients are left powerless when it comes to finding treatment options. Either they’re not eligible. Either they don’t even know that a trial is happening, so the trial itself shuts down due to no patients showing up to try it. That’s where Driver stepped in: the first platform of its kind set out to radically redefine how patients get visibility and access potentially life-extending treatments, when their current treatment plans were not working.
To build a strong yet flexible UX foundation that closes the massive gap between patients seeking experimental treatments and doctors and cancer centers ready to offer it.
We immediately looked into how people actually get information for their treatment. Main takeaway? Clear information is incredibly scattered and scarce. People are confused, frustrated, as they’re left to figure it out all on their own. Not on our watch. We wanted to put and end to all these incredibly important questions. Driver had the answers. We had an idea of how to make it feel friendly, reassuring, and easy to follow.
Driver was built to empower, motivate, and answer ungoogleable questions. The logo had to mirror that. That’s why we placed the dot at the end, to reinforce the platform’s authority in putting an end to really important questions, while softening it all with a warm, supportive, and friendly circular sans serif custom font.
The color scheme was inspired by the purple fluids of a DNA extraction process for detecting cancer. Purple is also the general cancer awareness color. So, we worked with a monochromatic palette that balanced strong and soft hues, allowing us to create unique color combos spanning from the website to the app to saliva kits to t-shirts and to other kinds of collateral.
Illustrations were a big part in humanizing this inexplicably dehumanized process. Keeping things light when facing hard situations was the positivity that we felt made all the difference. It made information easier to understand. It soothed. It stayed top of mind.
We designed several experiences and interfaces that aimed to make it the easiest ever to sign up and connect cancer patients with clinical trials, while also giving doctors a seamless access at treatments and trials by connecting them, in turn, to various universities and clinics throughout the country.